Cumberland Pharmaceuticals Inc CPIX Financial and Strategic SWOT Analysis Review [Report Updated: 17102017] Prices from USD $125

20:10 EST 12 Nov 2017 | BioPortfolio Reports

Cumberland Pharmaceuticals Inc CPIX Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.


Cumberland Pharmaceuticals Inc Cumberland Pharma is a pharmaceutical company which develops and commercializes branded prescription products. The company's product portfolio includes acetylcysteine, ibuprofen, lactulose, conivaptan, amifostine and ifetroban. It provides prescription products for hospitals, acute cares, unmet medical needs and gastroenterology. Cumberland Pharma's acetylcysteine is used for the prevention of liver damage resulting from acetaminophen overdose. The company works in partnership Phebra Pty Ltd, Teligent Pharmaceuticals Inc, DB Pharm Korea Co Ltd, Sandor Medicaids Pvt. Ltd for commercialization of the products internationally. It markets the branded products through a channel of network distributors in the US and abroad. Cumberland Pharma is headquartered in Nashville, Tennessee, the US.

Cumberland Pharmaceuticals Inc Key Recent Developments

Aug 08,2017: Cumberland Pharmaceuticals Reports Double Digit Revenue Growth for the Fourth Consecutive Quarter

May 15,2017: Cumberland Pharmaceuticals Reports Revenue Growth Of 25% In First Quarter 2017

Mar 07,2017: Cumberland Pharmaceuticals Reports Fourth Quarter And Full Year 2016 Financial Results

Jan 16,2017: Cumberland Pharmaceuticals Announces Kenneth J. Krogulski To Join Its Board Of Directors

Nov 01,2016: Cumberland Pharmaceuticals Reports Third Quarter Year To Date 2016 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Original Article: Cumberland Pharmaceuticals Inc CPIX Financial and Strategic SWOT Analysis Review [Report Updated: 17102017] Prices from USD $125


More From BioPortfolio on "Cumberland Pharmaceuticals Inc CPIX Financial and Strategic SWOT Analysis Review [Report Updated: 17102017] Prices from USD $125"

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...